New Jersey's Merck & Co to purchase Acceleron for $11.5bn in rare-disease-drug push - NewsBreak

Merck & Co Inc., the Kenilworth, New Jersey-headquartered American multinational pharmaceutical company initially established in Germany by a Merck family back in the 1668s, had been brewing off an option to an $11.5 billion purchase of Acceleron Pharma Inc largely in a bid to branch out its portfolio to rare cardiovascular diseases, widening collections beyond its best-selling aging cancer drug Keytruda.